The Akt and ERK activation by platinum-based chemotherapy in ovarian cancer is associated with favorable patient outcome. (Q43208984)
Jump to navigation
Jump to search
scientific article published in November 2009
Language | Label | Description | Also known as |
---|---|---|---|
English | The Akt and ERK activation by platinum-based chemotherapy in ovarian cancer is associated with favorable patient outcome. |
scientific article published in November 2009 |
Statements
The Akt and ERK activation by platinum-based chemotherapy in ovarian cancer is associated with favorable patient outcome (English)
Tsuyoshi Ohta
Masanori Isobe
Toshifumi Takahashi
Maki Saitoh-Sekiguchi
Teiichi Motoyama
Hirohisa Kurachi